Amicus Therapeutics
FOLD
FOLD
253 hedge funds and large institutions have $3.79B invested in Amicus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 93 increasing their positions, 76 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4.33% less ownership
Funds ownership: 113.29% → 108.96% (-4.3%)
20% less capital invested
Capital invested by funds: $4.71B → $3.79B (-$923M)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
253
Holding in Top 10
6
Calls
$6.36M
Puts
$5.25M
Top Buyers
| 1 | +$42.6M | |
| 2 | +$27.2M | |
| 3 | +$21.9M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$21.5M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$19.1M |
Top Sellers
| 1 | -$200M | |
| 2 | -$25.4M | |
| 3 | -$22.1M | |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$21.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$18.5M |